(Reuters) - Nearly a dozen countries resumed use of AstraZeneca’s COVID-19 shots on Friday as EU and British regulators said its benefits outweighed any risks. Reports of rare instances of blood clotting had temporarily halted inoculations.
TOKYO — Transportation minister Kazuyoshi Akaba says Japan will tighten border controls and limit the number of entrants to up to 2,000 per day to guard against the more contagious variants of the coronavirus.
WHO listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use, giving the green light for these vaccines to be rolled out globally through COVAX. The vaccines are produced by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India.
* Germany is planning to spend nearly 9 billion euros this year to buy up to 635.1 million COVID-19 vaccines as part of the European Union’s procurement scheme and national deals.
Recent Comments